Related Experiment Video
Updated: May 18, 2026

Heterokaryon Technique for Analysis of Cell Type-specific Localization
Published on: March 11, 2011
Androgen receptor on the move: boarding the microtubule expressway to the nucleus
Maria Thadani-Mulero1, David M Nanus, Paraskevi Giannakakou
1Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York, New York 10065-4896, USA.
Abstract:
Recent studies have shown that the microtubule-stabilizing drug paclitaxel, which is commonly used for the treatment of prostate cancer, inhibits signaling from the androgen receptor by inhibiting its nuclear accumulation downstream of microtubule stabilization. This mechanism is independent of paclitaxel-induced mitotic arrest and could provide an alternative mechanism of drug action that can explain its clinical activity. In this review, we highlight the importance of signaling and trafficking pathways that depend on intact and dynamic microtubules, and, as such, they represent downstream targets of microtubule inhibitors. We showcase prostate cancer, which is driven by the activity of the androgen receptor, as recent reports have revealed a connection between the microtubule-dependent trafficking of the androgen receptor and the clinical efficacy of taxanes. Identification and further elucidation of microtubule-dependent tumor-specific pathways will help us better understand the molecular basis of clinical taxane resistance as well as to identify individual patients more likely to respond to treatment.
Insights
Paclitaxel inhibits prostate cancer growth by blocking androgen receptor signaling, independent of cell division arrest. This microtubule-dependent mechanism offers new insights into taxane efficacy and resistance.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Prostate cancer is driven by androgen receptor (AR) signaling.
- Paclitaxel, a microtubule-stabilizing drug, is used in prostate cancer treatment.
- The precise mechanisms of paclitaxel's efficacy in prostate cancer are still being investigated.
Purpose of the Study:
- To review the role of microtubule-dependent pathways in cancer.
- To highlight the inhibition of androgen receptor signaling by paclitaxel.
- To explore the clinical implications of microtubule dynamics in prostate cancer treatment.
Main Methods:
- Review of recent studies on paclitaxel and androgen receptor signaling.
- Analysis of microtubule stabilization and its downstream effects.
- Examination of microtubule-dependent trafficking pathways.
Main Results:
- Paclitaxel inhibits androgen receptor nuclear accumulation, independent of mitotic arrest.
- Microtubule stabilization is crucial for androgen receptor signaling and trafficking.
- Taxane efficacy in prostate cancer is linked to microtubule-dependent AR trafficking.
Conclusions:
- Microtubule-dependent pathways are critical downstream targets for microtubule inhibitors.
- Paclitaxel's inhibition of AR nuclear accumulation provides a novel mechanism for its anti-cancer activity.
- Understanding these pathways can improve patient stratification and overcome taxane resistance.
Related Concept Videos
Intracellular Hormone Receptors
Internal Receptors
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
Signal Transduction: Overview
Typically, signal transduction involves three...
Nuclear Protein Sorting
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the timing and level of...

